Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Return on Equity (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Equity for 4 consecutive years, with 2.35% as the latest value for Q3 2020.

  • Quarterly Return on Equity fell 2183.0% to 2.35% in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 2.35% through Sep 2020, down 2183.0% year-over-year, with the annual reading at 23.08% for FY2019, 2447.0% up from the prior year.
  • Return on Equity for Q3 2020 was 2.35% at Forte Biosciences, up from 7.38% in the prior quarter.
  • The five-year high for Return on Equity was 40.04% in Q1 2019, with the low at 7.38% in Q2 2020.
  • Average Return on Equity over 4 years is 5.38%, with a median of 0.43% recorded in 2017.
  • The sharpest move saw Return on Equity soared 4070bps in 2019, then plummeted -3433bps in 2020.
  • Over 4 years, Return on Equity stood at 0.52% in 2017, then crashed by -305bps to 2.09% in 2018, then skyrocketed by 667bps to 11.83% in 2019, then plummeted by -120bps to 2.35% in 2020.
  • According to Business Quant data, Return on Equity over the past three periods came in at 2.35%, 7.38%, and 5.71% for Q3 2020, Q2 2020, and Q1 2020 respectively.